Relapse in resected lung cancer revisited: Does intensified follow up really matter? A prospective study

World Journal of Surgical Oncology

Volumn 7, Issue , 2009, Pages

  Subotic, Dragan ^a   Mandaric, Dragan ^a   Radosavljevic, Gordana ^a   Stojsic, Jelena ^a   Gajic, Milan ^b   Ercegovac, Maja ^a  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b Faculty of Medicine   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADENOSQUAMOUS CARCINOMA; ADRENAL METASTASIS; ADULT; AGED; ARTICLE; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EARLY INTERVENTION; FEMALE; FOLLOW UP; HUMAN; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; PLEURA; POSTOPERATIVE PERIOD; TREATMENT OUTCOME; LUNG RESECTION; LUNG TUMOR; METASTASIS; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TUMOR RECURRENCE;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PNEUMONECTOMY; POSTOPERATIVE PERIOD; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 71549146574     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-7-87     Document Type: Article

References (25)

1. Sawyer TE, Bonner JA, Gould PM, Foote RL, Deschamps C, Lange CM, Li H. Factors predicting patterns of recurrence after resection of N1 Non-Small Cell Lung Carcinoma. Ann Thorac Surg 1999, 68:1171-6. 10.1016/S0003-4975(99)00678-5, 10543475.
2. Tanaka F, Yanagihara K, Otake Y, Tomoko Y, Tsuyoshi S, Ryo M, Kenji I, Wada H. Prognostic factors in patients with resected pathologic (p-) T1-2N1 M0 non-small cell lung cancer (NSCLC). Eur J Cardiothorac Surg 2001, 19:555-61. 10.1016/S1010-7940(01)00670-4, 11343930.
3. Osaki T, Nagashima A, Yoshimatsu T, Tashima Y, Yasumoto K. Survival and characteristics of lymph node involvement in patientswith N1 non-small cell lung cancer. Lung Cancer 2004, 43:151-7. 10.1016/j.lungcan.2003.08.020, 14739035.
4. Martini N, Burt ME, Bains MS, McCormack PM, Rusch VW, Ginsberg RJ. Survival after resection of stage II non-small cell lung cancer. Ann Thorac Surg 1992, 54:460-6.
5. Yano T, Yokoyama H, Inoue T, Asoh H, Tayama K, Ichinose Y. Surgical results and prognostic factors of pathologic N1 disease in non-small cell carcinoma of the lung. Significance of N1 level: lobar or hilar nodes. J Thorac Cardiovasc Surg 1994, 107:1398-1402.
6. Ramacciato G, Paolini A, Volpino P, Aurello P, Balesh AM, D'Andrea N, Del Grande E, Passaro U, Tosato F, Fegiz G. Modality of failure following resection of stage I and stage II non-small cell lung cancer. Int Surg 1995, 80:156-61.
7. Gajra A, Newman N, Gamble P, Kohman LJ, Graziano SL. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small cell lung cancer. J Clin Oncol 2003, 21:1029-1033. 10.1200/JCO.2003.07.010, 12637467.
8. Massard G, Ducrocq X, Kochetkova EA, Porhanov VA, Riquet M. Sampling or node dissection for intraoperative staging of lung cancer: a multicentric cross-sectional study. Eur J Cardiothorac Surg 2006, 30:164-167. 10.1016/j.ejcts.2006.04.010, 16725340.
9. Keller S, Adak S, Wagner H, Johnson DH, . for the Eastern Cooperative Oncology group Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer. Ann Thorac Surg 2000, 70:358-366. 10.1016/S0003-4975(00)01673-8, 10969645.
10. Riquet M, Assouad J, Foucault C, Danel C. Visceral pleura invasion and lung cancer: further clarifications. Eur J Cardiothorac Surg 2004, 25:471. 10.1016/j.ejcts.2003.12.008, 15019685.
11. Ou SHI, Zell JA, Ziogas A, Culver HA. Prognostic Significance of the Non-Size-Based AJCC T2 Descriptors. Visceral Pleura Invasion, hilar Atelectasis, or obstructive pneumonitis in Stage IB Non-small Cell Lung Cancer is dependent on tumor size. Chest 2008, 133:662-669. 10.1378/chest.07-1306, 17925418.
12. Schirren J, Bergmann T, Beqiri S, Bolukbas S, Fisseler-Eckhoff A, Vogt-Moykopf I. Lymphatic spread in resectable lung cancer: can we trust in a sentinel lymph node?. Thorac Cardiovasc Surg 2006, 54:373-380. 10.1055/s-2006-924194, 16967372.
13. Marom EM, Sarvis S, Herndon JE, Patz EF. T1 lung cancers: sensitivity of diagnosis with fluorodeoxyglucose PET. Radiology 2002, 223:453-459. 10.1148/radiol.2232011131, 11997552.
14. Cerfolio RJ, Ojha B, Bryant AS, Bass CS, Bartalucci AA, Mountz JM. The role of FDG-PET scan in staging patients with non-small cell carcinoma. Ann Thorac Surg 2003, 76:861-866. 10.1016/S0003-4975(03)00888-9, 12963217.
15. Gajra A, Newman N, Gamble GP, Abraham NZ, Kohman LJ, Graziano SL. Impact of tumor size on survival in stage IA non-small cell lung cancer: a case for subdividing stage IA disease. Lung Cancer 2003, 42:51-57. 10.1016/S0169-5002(03)00285-X, 14512187.
16. Veeramachaneni NK, Battafarano RJ, Meyers BF, Zoole JB, Patterson GA. Risk factors for occult nodal metastasis in clinical T1N0 lung cancer: a negative impact on survival. Eur J Cardiothorac Surg 2008, 33:466-469. 10.1016/j.ejcts.2007.12.015, 18249130.
17. Riquet M, Manac'h D, Le Pimpec Barthes F, Dujon A, Debrosse D, Debesse B. Prognostic value of T and N in non-small cell lung cancer three centimeters or less in diameter. Eur J Cardiothorac Surg 1997, 11:440-443. 10.1016/S1010-7940(96)01019-6, 9105805.
18. Vansteenkiste JF. PET scan in the staging of non-small cell lung cancer. Lung Cancer 2003, 42:S27-S37. 10.1016/S0169-5002(03)00302-7, 14611912.
19. Weder W, Schmid RA, Bruchhaus H, Hillinger S, von Schulthess GK, Steinert HC. Detection of extrathoracic metastases by positron emission tomography in lung cancer. Ann Thorac Surg 1998, 66:886-892. 10.1016/S0003-4975(98)00675-4, 9768946.
20. Stroobants SG, D'Hoore I, Dooms C, De Leyn PR, Dupont PJ, De Wever W, De Groot T, Verschakelen JA, Mortelmans LA, Vansteenkiste JF. Additional value of whole body fluorodeoxyglycose positron emission tomography in the detection of distant metastases of non-small-cell lung cancer. Clin Lung Cancer 2003, 4:242-247. 10.3816/CLC.2003.n.005, 14624714.
21. Gross B, Glazer G, Orringer M, Spizarny D, Flint A. Bronchogenic carcinoma metastatic to normal-sized lymph nodes: frequency and significance. Radiology 1988, 166:71-74.
22. Arita T, Matsumoto T, Kuramitsu T, Kawamura N, Sugi K, Esato K. Is it possible to differentiate malignant mediastinal nodes from benign nodes by size? Reevaluation by CT, transesophageal echocardiography and nodal specimen. Chest 1996, 110:1004-1008. 10.1378/chest.110.4.1004, 8874260.
23. Lee YC, Tu Wu C, Wen Kuo S, Tseng YT, Chang YL. Significance of extranodal extension of regional lymph nodes in surgically resected non-small cell lung cancer. Chest 2007, 131:993-999. 10.1378/chest.06-1810, 17426201.
24. Yamanaka S, Hirai T, Takahashi A, Konishi F. Analysis of lobar lymph node metastases around the bronchi of primary and nonprimary lobes in lung cancer. Risk of remnant tumor at the root of the nonprimary lobes. Chest 2002, 121:112-117. 10.1378/chest.121.1.112, 11796439.
25. Fujimoto T, Cassivi SD, Yang P, Barnes SA, Nichols FC, Deschamps C, Allen MS, Pairolero PC. Completely resected N1 non-small cell lung cancer: factors affecting recurrence and long-term survival. J Thorac Cardiovasc Surg 2006, 132:499-506. 10.1016/j.jtcvs.2006.04.019, 16935101.